Prurigo Nodularis
Dermatology
Prurigo Nodularis is treated with 3 medications in our database, including Dupixent, KYGEVVI, NEMLUVIO. 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Sanofi, Alnylam, Galderma. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Prurigo Nodularis treatment below.
What help exists for Prurigo Nodularis
3
drugs indexed
3
with copay cards
3
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Prurigo Nodularis
3 totalDupixent
Dupilumab · Sanofi
🎟💙KYGEVVI
doxecitine and doxribtimine · Adaptimmune
🎟💙NEMLUVIO
nemolizumab-ilto · Galderma
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Prurigo Nodularis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |